HNN3.0
Register
Register
Register

Project cooperationUpdated on 11 December 2025

ECRIN: Pan‑European Infrastructure Partner for Multinational Clinical Trials in Horizon Europe Health 2026–2027

Project Manager at European Clinical Research Infrastructure Network (ECRIN)

Paris, France

About

ECRIN is a European Research Infrastructure (ERIC, ESFRI Landmark) supporting the design, set-up and conduct of high-quality multinational clinical studies. Through its national networks of Clinical Trial Units (CTUs), ECRIN provides coordinated services for protocol development, regulatory and ethics submissions, contracts, monitoring, pharmacovigilance, data management and quality management across Europe.

ECRIN seeks to join consortia planning multi-country interventional or complex clinical research, including large pan-European trials, deep-phenotyping cohorts, pragmatic/implementation trials, or innovative study designs.

ECRIN contributes to:

  • Study methodology, trial design and trial governance

  • Funding application support, cost evaluation, protocol per review

  • Operational feasibility assessments and trial delivery

  • Regulatory/ethics strategy & national submissions

  • Harmonised data management, FAIR/metadata practices

In addition to trial operations, ECRIN also participates/coordinates infrastructure development projects that strengthen the foundations of clinical research in Europe. Rather than producing clinical trial results, these projects focus on creating or improving the structures that support clinical research, such as data platforms, trial networks, regulatory support systems, or digital tools. Through this work, ECRIN contributes to:

  • Capacity building: strengthening institutions, networks, or countries to conduct rigorous clinical research, establishing shared services, and supporting training programmes.

  • Interoperability and integration: connecting registries, data repositories, trial sites and tools into harmonised frameworks.

  • Sustainability and long-term service provision: Contributes to creating infrastructures that will provide services to the research community beyond the end of the project.

Expertise - what we offer

  • Pan‑European infrastructure for multinational interventional and complex clinical studies

  • End‑to‑end clinical trial support: feasibility, protocol review, regulatory strategy, ethics, national submissions, contracts, monitoring, pharmacovigilance, data management, quality and risk‑based monitoring

  • Proven experience as partner in FP7 / H2020 / Horizon Europe projects across many disease areas (infectious disease, neurology, cardiology, rare diseases, oncology, etc.).

  • Network of national partners (CTUs) enabling recruitment, on‑site activities and harmonised procedures in many European countries.

  • Expertise in trial methodology, governance models, data standardisation, FAIR data, and connection with other Research Infrastructures (e.g. BBMRI, EATRIS, ELIXIR, EURO-BIOIMGING, etc) and data sharing initiatives (e.g. EOSC, EHDS)

  • Leadership/participation in clinical research infrastructure development projects (capacity building, digital tools, sustainable services)

What ECRIN is looking for

  • Coordinators and consortia planning large, multi‑country clinical trials or complex clinical studies under the 2026 Health calls (especially DISEASE, some STAYHLTH and TOOL/IND topics with major clinical components)

  • Partners interested in designing methodologically robust, GCP‑compliant pragmatic or implementation trials (e.g. NCD prevention, long‑term conditions, cardiovascular and neurodegenerative diseases).

  • Collaborations on sustainable clinical research infrastructures, capacity building, and harmonised data/quality frameworks across Member States.

Topic

  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
  • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
  • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    Hospital-based Translational Research & Clinical Trials Partner

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Iacopo Megna

    Clinical Project Manager - Grant Officer at University Hospital SS Antonio e Biagio e C. Arrigo

    Alessandria, Italy

  • Project cooperation

    Designing clinical Trials and epidemiologhical studies

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 4: HORIZON-HLTH-2026-01-CARE-03: Identifying and addressing low-value care in health and care systems
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
    • DESTINATION 2: HORIZON-HLTH-2026-01-ENVHLTH-01: Towards a better understanding and anticipation of the impacts of climate change on health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Sayoki G Mfinanga

    Professor epidemiology and Global Health at National Institute for Medical Research, Muhimbili Centre

    Dar es Salaam, Tanzania, United Republic Of

  • Project cooperation

    Critical care and ICU researcher

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions

    Mariachiara Ippolito

    Researcher at Università degli Studi di Palermo

    Palermo, Italy